Efficacy of a new selective steroid (GW870086) in asthma: An adaptive, randomised, controlled trial

Current Drug Therapy

Volumn 8, Issue 2, 2013, Pages 69-75

  Bareille, Philippe ^a   Hardes, Kelly ^a   Robertson, Jonathan ^a   Davis, Angela ^b   Allen, Ann ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Diskhaler; Glucocorticoid; Inhaled corticosteroid; Repeat dose

Indexed keywords

RANDOMIZED CONTROLLED TRIAL;

EID: 84892968436     PISSN: 15748855     EISSN: 10657630     Source Type: Journal    
DOI: 10.2174/1574885511308020001     Document Type: Article

References (14)

1. Barnes PJ. Corticosteroid effects on cell signalling. Eur Resp J 2006; 27: 413-26.
2. Newton R, Holden NS. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor? Mol Pharmacol 2007; 72: 799-809.
3. Uings I, Needham D, Matthews J, et al. GW870086: A potent antiinflammatory steroid with a unique pharmacological profile. Br J Pharmacol 2013; 169(6): 1389-403.
4. Allen A, Bareille P, Hardes K, Robertson J. Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GW870086: Two Randomised Studies. Curr Drug Ther 2013; 8(2): 76-85.
5. Bareille P, Allen A, Hardes K, Donald A. Effect of a Novel Selective Inhaled Steroid on the Allergen-Induced Early and Late Asthmatic Response in Adults with Mild Asthma: A Randomised Study. Curr Drug Ther 2013; in press.
6. Pincus DJ, Szefler SJ, Ackerson LM, Martin RJ. Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995; 95: 1172-8.
7. Martin RJ, Banks-Schlegal S. Chronobiology of Asthma. NHBLI Workshop Summary. Am J Crit Care Med 1998; 158: 1002-7.
8. Muers MF. Diurnal variation in asthma. Arch Dis Child 1984; 59: 898-901.
9. Tepper RS, Wise RS, Covar R, et al. Asthma outcomes: Pulmonary physiology. J Allergy Clin Immunol 2012; 129: S65-87.
10. Szefler SJ, Wohlberg H, Lambert H, Martin RJ. Lessons learned from variation in response to therapy in clinical trials: The role of the allergist-immunologist in personalized medicine. J Allergy Clin Immunol 2010; 125: 285-94.
11. Zeiger RS, Baker JW, Kaplan MS, et al. Variability of symptoms in mild persistent asthma: baseline data from the MIAMI study. Respir Med 2004; 98: 898-905.
12. O'Byrne PM. How much is too much? The treatment of mild asthma. Eur Respir J 2007; 30: 403-6.
13. Donohue JF, Ohar JA. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004; 1: 152-60.
14. Kelly HW. Comparative potency and clinical efficacy of inhaled corticosteroids. Respir Care Clin North Am 1999; 5: 537-53.